Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Atypical Antipsychotics for Schizophrenia: Combination Therapy and High Doses — Project Protocol [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Aug. (CADTH Optimal Use Report, No. 1.1.)
Atypical Antipsychotics for Schizophrenia: Combination Therapy and High Doses — Project Protocol [Internet].
Show details- Tarun K. Ahuja, PhDResearch Officer
- Chris Cameron, BSc EngDip MScHealth Economist
- Trinh LuongDirector HTA and Optimal Use
- Changhua Yu, MD MScResearch Officer
- Nancy RobertsonKnowledge Exchange Officer
- Sarah Neiman-MacDonaldProject Manager
- David Kaunelis, MLISInformation Specialist
- Sumeet R. Singh, BScPhm MSc RPhManager, Clinical Research
- Samantha Verbrugghe, BScResearch Assistant
- Kristen MoultonResearch Assistant
- Janet CrainManager, Knowledge Exchange
- Pat ReynardProject Manager
- Contributors from CADTH - Atypical Antipsychotics for Schizophrenia: Combination...Contributors from CADTH - Atypical Antipsychotics for Schizophrenia: Combination Therapy and High Doses — Project Protocol
Your browsing activity is empty.
Activity recording is turned off.
See more...